Skip to main content
T

The Cigna Group Ventures

Unclaimed
Est. 2018$700M AUMUpdated Is this your firm? Suggest a correction

At a Glance

Stage
Series A, Series B+
AUM
$700M
Sectors
Digital Health, AI
Founded
2018

About The Cigna Group Ventures

The Cigna Group Ventures, originally branded Cigna Ventures, is the strategic venture fund of The Cigna Group, the health services company that operates Cigna Healthcare and Evernorth Health Services. The unit's site gives 2018 as its founding year and reports $700 million in assets under management, 24 investments and a 92 percent partnership rate, meaning most portfolio companies have a commercial relationship with The Cigna Group. The unit states that, while strategically aligned with its parent, it keeps the autonomy to make investment decisions with the rigor and speed of a financial investor.

It invests in early and growth stage whole-person health services and technology companies whose products can broaden access, enhance support and drive better value for Cigna's customers. The portfolio covers virtual and in-home care (MDLIVE, Monogram Health, Contessa, 9amHealth), behavioral health (Headspace, Alma, NOCD, Octave), condition management (Omada, Cleerly, OncoHealth, Zerigo), women's and maternal health (Visana Health, Babyscripts), and data and AI infrastructure (Datavant, Arcadia, Prognos Health, Autonomize AI). Recent disclosed deals include Visana Health's $24 million Series A in September 2025, Autonomize AI's $28 million Series A in June 2025, and a $9.5 million Series A extension for 9amHealth in 2024 that the unit led.

The unit's case studies describe how investments turn into distribution. Omada's enrolled membership grew 650 percent after partnering with the unit in 2017, and Omada became a preferred provider on Evernorth's Digital Health Formulary. MDLIVE moved from vendor to strategic partner and is now an Evernorth subsidiary. Ginger, which merged with Headspace in 2021, scaled behavioral care access during the partnership. Several companies have exited, including Cricket Health's 2022 merger with Interwell and Fresenius, and RecoveryOne's 2024 acquisition by TailorCare.

Investment Thesis

“The unit says investing is more than capital and that it partners with entrepreneurs to unlock opportunities to broaden access to care, enhance support and drive better value. It focuses on whole-person health services and technology companies at early and growth stages, and its stated model is bi-directional strategic value: portfolio companies gain access to the people, resources and partnership opportunities of one of the largest health service companies, while The Cigna Group gains solutions for its 170 million plus customers. It maintains decision-making autonomy so it can move with the rigor and speed of a traditional financial investor.”

Sector Focus

Investment Stage

Pre-Seed
Seed
Series ASeries B+

Notable Portfolio Companies

OOmada
MMDLIVE
HHeadspace
DDatavant
AAlma
MMonogram Health
CCleerly
NNOCD
99amHealth
VVisana Health

Key Team (8)

C

Craig Cimini

Head of The Cigna Group Ventures

R

Rachel Anderson

Senior Principal, Portfolio Partnerships

M

Matthew Blum

Senior Principal

A

Amir Debourou

Principal

N

Nikolas Koenning

Principal

A

Ajay Shimoga

Principal

J

Jack McNeilly

Associate

K

Kristin Stafford

Operations & Administrative Coordinator

Fund History

The unit reports $700 million in assets under management, a 2018 founding and 24 investments. It is described as the strategic venture fund of The Cigna Group and invests corporate capital rather than money from outside limited partners. Its own case studies date its relationship with Omada to 2017, before the stated founding year, which suggests earlier corporate investing that was later consolidated into the unit. The unit has led rounds (9amHealth, 2024) and joined syndicates (Autonomize AI and Visana Health, 2025). No Form D filings in the unit's name were identified.

Frequently Asked Questions

What stage does The Cigna Group Ventures invest at?

The Cigna Group Ventures primarily invests at the Series A, Series B+ stages. This means they focus on companies that are scaling their go-to-market after proving product-market fit.

What sectors does The Cigna Group Ventures focus on?

The Cigna Group Ventures focuses on investments in Digital Health, AI. Their portfolio reflects deep expertise and networks within these sectors.

How much does The Cigna Group Ventures have under management?

The Cigna Group Ventures manages approximately $700M in assets under management (AUM) across their funds.

Fund Operations Resources

Running a fund like The Cigna Group Ventures? Independent guides to the software and processes emerging managers use to operate.

Related tools and reading

Sponsored
AArchstone

The operating system for private capital.

Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.

LP portalCapital calls$297/moNo AUM fees
Book a demo